| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 3-Jan-09 | | Total Revenue | 448,039 | 397,644 | 412,100 | 517,160 | | Cost of Revenue | 359,343 | 320,365 | 348,316 | 410,573 | | | Gross Profit | 88,696 | 77,279 | 63,784 | 106,587 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 52,570 | 48,370 | 52,515 | 58,160 | | Non Recurring | 8,537 | 32,031 | 8,732 | 377,019 | | Others | 2,587 | 2,355 | 2,316 | 2,261 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,002 | (5,477) | 221 | (330,853) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (266) | 1,896 | 17,607 | 19,579 | | Earnings Before Interest And Taxes | (54,653) | (3,581) | 17,828 | (311,274) | | Interest Expense | (50,352) | 27,807 | 22,545 | 27,373 | | Income Before Tax | (4,301) | (31,388) | (4,717) | (338,647) | | Income Tax Expense | 4,131 | (13,547) | (530) | (28,961) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,432) | (17,841) | (4,187) | (309,686) | | | Non-recurring Events | | Discontinued Operations | 9,505 | (411) | (124) | 63 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,073 | (18,252) | (4,311) | (309,623) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,073 | ($18,252) | ($4,311) | ($309,623) |
|
0.83% Nasdaq 0.00%
Income Statement
